All About Diabetes

NCBI Bookshelf. A division of the National Library of Medicine, National Institutes of Health.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.

StatPearls [Internet].

Amit Sapra ; Priyanka Bhandari .

Contributors

Affiliations

Last Revision: June 21, 2023 .

Continuing Education Activity

Diabetes mellitus is characterized by poor regulation of blood sugar levels, with different types like type 1, type 2, MODY, gestational diabetes, neonatal diabetes, and steroid-induced diabetes. Both type 1 and type 2 diabetes can lead to high blood sugar levels. This article explores the causes, assessment, and treatment of diabetes mellitus and stresses the importance of a collaborative healthcare team in caring for patients with this disease.

Recognize the significance of enhancing teamwork and care coordination among healthcare professionals to improve patient care for individuals affected by diabetes mellitus.

It is essential for healthcare professionals to work together effectively in managing diabetes mellitus. This involves regular communication, sharing of information, and coordinated efforts to provide comprehensive care for patients. Team members may include endocrinologists, primary care physicians, dietitians, nurses, pharmacists, and diabetes educators.

Complications of Diabetes Mellitus

Diabetes mellitus can lead to a range of complications if left uncontrolled. These complications can affect various parts of the body, such as the eyes, kidneys, nerves, and cardiovascular system.

One of the most common complications of diabetes is diabetic retinopathy, a condition that affects the blood vessels in the retina of the eye. This can lead to vision loss and blindness if not managed properly. Another common complication is diabetic nephropathy, which affects the kidneys and can eventually lead to kidney failure.

Diabetes can also cause nerve damage, known as diabetic neuropathy, which can result in pain, numbness, and tingling in the affected areas. Additionally, individuals with diabetes are at a higher risk of developing cardiovascular diseases, such as heart attacks and strokes, due to the impact of high blood sugar levels on the blood vessels.

It is important for individuals with diabetes to closely monitor their blood sugar levels and follow a healthy lifestyle to prevent the development of these complications. Regular medical check-ups and screenings are also essential to detect any potential issues early on.

Etiology

In the pancreatic islets of Langerhans, beta cells release insulin, while alpha cells secrete glucagon. An imbalance between insulin and glucagon levels results in hyperglycemia in diabetes. Type 1 diabetes is caused by the destruction of beta cells, while type 2 diabetes involves insulin resistance and deficiencies in insulin function.

Genetics significantly influence the risk of developing diabetes mellitus, with various genetic loci identified as risk factors for type 1 and type 2 diabetes. Lifestyle choices also contribute to the onset of type 2 diabetes.

Epidemiology

Approximately 1 in 11 adults globally have diabetes, with type 2 diabetes being the most prevalent form. Type 1 diabetes typically emerges in early childhood, while type 2 diabetes is more common in older age groups, particularly in obese adolescents. The prevalence of diabetes varies among different ethnic groups and is projected to rise worldwide by 2040.

Risk factors for developing type 2 diabetes include genetics, obesity, unhealthy diet, lack of physical activity, and older age. In addition to these factors, gestational diabetes is a specific type that affects pregnant women and increases the risk of developing type 2 diabetes later in life.

Pathophysiology

Individuals diagnosed with DM may experience elevated blood sugar levels due to impaired function of pancreatic beta cells. Osmotic diuresis can occur at increased blood glucose levels, leading to symptoms like increased urination and thirst.

Insulin resistance is associated with excessive fatty acids and proinflammatory cytokines, negatively affecting glucose transport and fat metabolism. Inadequate insulin production or response boosts glucagon levels, worsening hyperglycemia. Prolonged high blood sugar levels lead to nonenzymatic glycation and harm to small blood vessels, resulting in complications such as retinopathy, nephropathy, and neuropathy.

The diagnosis of T1DM usually relies on specific symptoms and elevated blood glucose levels, while T2DM can be detected through fasting glucose levels and HbA1c testing. Prediabetes may precede T2DM, showing specific glucose level patterns.

Laboratory tests like self-monitoring blood glucose and HbA1c assessment are vital in managing chronic DM. Urine albumin and serum lipid tests help detect early signs of complications. Treatment involves dietary adjustments, physical activity, and potentially insulin or other medications to regulate blood sugar levels and prevent complications.

Regular screenings play a critical role in identifying and managing microvascular complications. Eye exams, neurological evaluations, and foot checks aid in preventing severe complications. Medications like ACE inhibitors, ARBs, and other drugs may be prescribed to manage neuropathy and other symptoms.

Effective disease management requires patient education, lifestyle modifications, and continuous monitoring to maintain healthy glucose levels and avert complications.

The ADA recommends routine blood pressure checks for diabetic individuals to achieve specific goals. Pharmacological treatment typically involves several medications like ACE inhibitors, ARBs, diuretics, beta-blockers, and calcium channel blockers. Monitoring lipid levels is crucial, with statins being the primary treatment for abnormal lipid profiles. Aspirin may benefit high-risk diabetic patients, but its efficacy in reducing cardiovascular events remains unclear.

Various disorders affecting the pancreas can trigger diabetes mellitus, alongside other conditions like hormonal imbalances and drug-induced insulin resistance, which must be considered during diagnosis.

Studies have explored the cardiovascular outcomes of different antidiabetic medications, showing positive results in reducing mortality and cardiovascular events. Insulin and other drugs utilized to manage diabetes can have adverse effects, including gastrointestinal disturbances, lactic acidosis, and hypoglycemia.

Diabetes mellitus significantly impacts morbidity and mortality, affecting multiple organ systems and leading to diverse complications. Uncontrolled diabetes heightens the risk of microvascular, macrovascular, and neuropathic complications, increasing the likelihood of cardiovascular issues. Diabetic retinopathy, kidney disease, neuropathy, and amputations are common complications associated with diabetes.

Diabetes stands as a primary cause of vision loss and kidney disorders. Regular monitoring and proper glucose management are essential in preventing and slowing disease progression. Maintaining optimal blood pressure levels is crucial in lowering complication risks like macular edema.

Research suggests a potential association between diabetes and cancer, with specific medications influencing cancer-related outcomes. Gestational diabetes raises the likelihood of cesarean deliveries and chronic hypertension, with special considerations for neonatal complications in infants born to diabetic mothers.

The most acute complication of diabetes is diabetic ketoacidosis (DKA) in T1DM, resulting from inadequate dosage, missed doses, or concurrent infections. Insulin deficiency renders tissues unable to extract glucose from the blood, prompting the use of lipid metabolism for energy in the form of ketones, causing systemic acidosis termed as high anion-gap metabolic acidosis. Hyperglycemia and ketosis induce diuresis, acidosis, and vomiting, leading to dehydration and electrolyte imbalances. In T2DM, hyperosmolar hyperglycemic syndrome (HHS) resembles DKA but with fewer urinary ketones due to insulin release by pancreatic beta cells. Treatment involves insulin administration, aggressive IV fluid replacement, and meticulous electrolyte management.

Healthcare providers should actively educate diabetic patients on lifelong lifestyle changes for effective disease management. Personalized education proves more beneficial than group sessions for patients struggling to control their diabetes. Non-clinical healthcare providers such as nurses and pharmacists often have more time to provide individualized education.

Metabolic changes in amino acid metabolism may influence T2DM development, with elevated levels of isoleucine, phenylalanine, and tyrosine observed in individuals with hyperglycemia. These amino acids could serve as early indicators of metabolic syndrome progression and contribute to the associated inflammatory state.

Primary care physicians frequently diagnose diabetes and necessitate an interprofessional team approach for treatment. Various healthcare professionals like dietitians, diabetes educators, eye specialists, neurologists, podiatrists, kidney specialists, and endocrinologists contribute to patient care. Pharmacists play a crucial role in medication management and preventing medication overload in diabetic patients.

Multiple studies delve into the genetic links to diabetes, with genome-wide investigations pinpointing loci linked to susceptibility to type 2 diabetes. The molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young are also subjects of scrutiny in medical literature.

Felner EI, Klitz W, Ham M, Lazaro AM, Stastny P, Dupont B, White PC. Genetic interaction among three genomic regions creates distinct contributions to early – and late-onset type 1 diabetes. Pediatr Diabetes. 2005 Dec; 6 (4):213-20. [PubMed : 16390390 ]

Writing Group for the SEARCH for Diabetes in Youth Study Group. Dabelea D, Bell RA, D’Agostino RB, Imperatore G, Johansen JM, Linder B, Liu LL, Loots B, Marcovina S, Mayer-Davis EJ, Pettitt DJ, Waitzfelder B. Incidence of diabetes in youth in the United States. JAMA. 2007 Jun 27; 297 (24):2716-24. [PubMed : 17595272 ]

Gale EA, Gillespie KM. Diabetes and gender. Diabetologia. 2001 Jan; 44 (1):3-15. [PubMed : 11206408 ]

Mamoulakis D, Galanakis E, Bicouvarakis S, Paraskakis E, Sbyrakis S. Epidemiology of childhood type I diabetes in Crete, 1990-2001. Acta Paediatr. 2003 Jun; 92 (6):737-9. [PubMed : 12856988 ]

Tuomilehto J. The emerging global epidemic of type 1 diabetes. Curr Diab Rep. 2013 Dec; 13 (6):795-804. [PubMed : 24072479 ]

Patterson CC, Dahlquist GG, Gyurűs E, Green A, Soltész G., EURODIAB..

Tuomilehto J. The emerging global epidemic of type 1 diabetes. Curr Diab Rep. 2013 Dec; 13 (6):795-804. [PubMed : 24072479 ]

The incidence of childhood type 1 diabetes in Europe and the United States has been increasing, as shown by several studies conducted over the past few decades. Additionally, the prevalence of type 2 diabetes has also been on the rise globally.
Various research studies have focused on different aspects of diabetes, including the impact of lifestyle interventions, medication, and the relationship between diabetes and other health conditions. These studies have provided valuable insights into the management and prevention of diabetes-related complications.
Furthermore, there is ongoing research on the potential benefits and risks of different treatments for diabetes, such as the use of aspirin and other medications. This research aims to improve the quality of care for individuals with diabetes and reduce the risk of complications associated with the condition.
Overall, the growing body of research on diabetes underscores the importance of early detection, effective management, and continued research efforts to address the global burden of this disease.
1. Metformin has been linked to improved survival in cancer patients with type 2 diabetes in a systematic review and meta-analysis.
2. Obstetric and perinatal outcomes in pregnancies affected by Type 1 and Type 2 diabetes are influenced by factors such as glycemic control, obesity, and social disadvantage.
3. DKA remains a concern in pediatric T1DM, sparking a debate on the topic.
4. A review of acute decompensated diabetes in adult patients covers diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome.
5. A randomized controlled trial compares the effectiveness of different patient education methods for type 2 diabetes.
6. Metabolite profiles can indicate the risk of developing diabetes.
7. Trimethylamine-N-oxide and its precursors undergo changes in nascent metabolic syndrome.
8. Amino acid levels contribute to the pro-inflammatory burden in nascent metabolic syndrome.
9. Nascent metabolic syndrome is explored through metabolomics.
10. Lipidomics is investigated in patients with nascent Metabolic Syndrome.
11. Amit Sapra and Priyanka Bhandari have no financial relationships with ineligible companies.